Editas Medicine
4 employees
Biotech
Public · $210.0M
Open positions (6)
Company details
Team Size4
IndustryBiotech
Funding
Total raised
$210.0M
Last stage
Public
Investors
Flagship Ventures
Total raised
$210.0M
Last stage
Public
Investors
Feng Zhang
Researcher at the MIT-Harvard Broad Institute; one of the pioneers of CRISPR-Cas9 gene editing in eukaryotic cells.
George Church
Harvard geneticist and genome engineering pioneer; co-founded Editas Medicine in 2013.
David R. Liu
Harvard University/Howard Hughes Medical Institute scientist; world leader in genome editing and base editing technologies.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.